Currently, Exelixis Inc [EXEL] is trading at $44.81, up 1.70%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The EXEL shares have gain 1.68% over the last week, with a monthly amount glided 7.74%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Exelixis Inc [NASDAQ: EXEL] stock has seen the most recent analyst activity on July 08, 2025, when RBC Capital Mkts downgraded its rating to a Sector Perform and also boosted its price target to $50 from $45. Previously, Stephens upgraded its rating to Overweight on June 24, 2025, and kept the price target unchanged to $60. On February 24, 2025, downgrade downgraded it’s rating to Equal Weight but maintained its price target of $36 on the stock. Morgan Stanley upgraded its rating to a Overweight and increased its price target to $40 on January 27, 2025. Oppenheimer downgraded its rating to a Perform. BMO Capital Markets downgraded its rating to Market Perform for this stock on December 20, 2024, and upped its price target to $40. In a note dated December 17, 2024, BofA Securities downgraded an Neutral rating on this stock and boosted its target price from $35 to $39.
This stock has fluctuated between a low of $22.20 and a high of $49.62 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $46 within the next 12 months. Exelixis Inc [NASDAQ: EXEL] shares were valued at $44.81 at the most recent close of the market. An investor can expect a potential return of 2.66% based on the average EXEL price forecast.
Analyzing the EXEL fundamentals
Trailing Twelve Months sales for Exelixis Inc [NASDAQ:EXEL] were 2.30B which represents 30.62% growth. Gross Profit Margin for this corporation currently stands at 0.97% with Operating Profit Margin at 0.33%, Pretax Profit Margin comes in at 0.36%, and Net Profit Margin reading is 0.28%. To continue investigating profitability, this company’s Return on Assets is posted at 0.23, Equity is 0.29 and Total Capital is 0.31. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 44.37 points at the first support level, and at 43.93 for the second support level. However, for the 1st resistance point, the stock is sitting at 45.05, and for the 2nd resistance point, it is at 45.29.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Exelixis Inc [NASDAQ:EXEL] is 3.50. As well, the Quick Ratio is 3.44, while the Cash Ratio is 0.46. Considering the valuation of this stock, the price to sales ratio is 5.32, the price to book ratio is 5.78 and price to earnings (TTM) ratio is 20.33.
Transactions by insiders
Recent insider trading involved Eckhardt Sue Gail, Director, that happened on Jun 02 ’25 when 18838.0 shares were sold. Director, WYSZOMIERSKI JACK L completed a deal on Jun 03 ’25 to sell 7535.0 shares. Meanwhile, Director JACK L WYSZOMIERSKI bought 7535.0 shares on Jun 03 ’25.
